GTS Securities’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-135,505
| Closed | -$224K | – | 1524 |
|
|
2024
Q3 | $224K | Buy |
135,505
+28,396
| +27% | +$46.9K | ﹤0.01% | 1485 |
|
|
2024
Q2 | $238K | Buy |
107,109
+32,713
| +44% | +$72.6K | ﹤0.01% | 1297 |
|
|
2024
Q1 | $199K | Buy |
74,396
+47,286
| +174% | +$127K | ﹤0.01% | 1209 |
|
|
2023
Q4 | $81.1K | Buy |
27,110
+12,983
| +92% | +$38.8K | ﹤0.01% | 1396 |
|
|
2023
Q3 | $13.8K | Buy |
+14,127
| New | +$13.8K | ﹤0.01% | 1316 |
|